Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

191,881-191,940 of 319,975

filter-aware
30
The slide uses two charts to show market growth and pipeline maturity.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · MarketLoop · Why Now1 hit
31
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Scientific, Commercial, etc.) to specific therapeutic area business models.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
32
The slide uses a 2x2 matrix to map specific industry players against two strategic dimensions.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
33
Uses a 2x2 matrix to represent the platform components.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
34
The slide uses a process flow diagram to illustrate data ingestion, NLP-based extraction, and the resulting knowledge graph.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
35
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
36
The slide uses a process flow framework to detail the specific steps in the Target ID phase, including TPA (Target Progressibility Assessment).BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
37
The slide uses a vertical timeline on the left to anchor the four steps: Tech Approach, Predict, Triage, and Assay.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
38
The central circular diagram represents a feedback loop between lab capabilities and data integration.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
39
The slide uses a flowchart to illustrate the adaptive clinical trial design.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
40
The slide outlines a clinical trial process flow with specific durations and patient ratios.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
41
Includes multiple charts showing inhibition of cytokines and reduction of inflammation.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
42
The diagram uses a process flow to show where BEN-2293 fits into the treatment landscape relative to existing therapies.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
43
The slide uses a process flow framework to explain the drug discovery pipeline.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
44
Includes a biological pathway diagram, a volcano plot for differential expression, and a tissue-specific RNAseq expression chart.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
45
The slide uses a causal chain framework to link PDE10 inhibition to therapeutic outcomes.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
46
The slide uses a comparison table to contrast the drug's mechanism of action against competitors and highlights safety concerns with current standards of care.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
01
Slide 1
The brain graphic is a stylized circuit board, representing the intersection of neuroscience and technology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
02
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
03
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Problem1 hit
04
SAD stands for Social Anxiety Disorder. The slide uses a metaphorical illustration of a person being scrutinized under a magnifying glass.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Problem1 hit
05
Speed Bump cartoon by Dave Coverly, 2011.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a yellow callout box to provide context for the quote.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
07
Data source: Kessler RC et al. Arch Gen Psychiatry 2005;62:593-602 and 617-627.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Market Size1 hit
08
The slide highlights Social Anxiety Disorder in red text.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide provides prevalence statistics and demographic correlations for SAD.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Market Size1 hit
10
The slide uses a tree-like structure to categorize various mental health conditions under the umbrella of Anxiety Disorders, while also showing related categories like OC & Related Disorders and Trauma and Stressor-Related Disorders.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
11
The slide uses a humorous illustration to emphasize the common fear of public speaking.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
12
SAD stands for Social Anxiety Disorder.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
13
The slide uses a complex overlapping circle diagram to map psychiatric conditions. Source: Stein MB & Stein DJ. Lancet 2008.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
14
The slide uses a complex overlapping circle diagram to map psychiatric conditions. Source: Stein MB & Stein DJ. Lancet 2008.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
15
The slide outlines a standard clinical decision-making process for pharmacotherapy.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
16
SAD likely refers to Social Anxiety Disorder. The image uses a metaphor of a single red figure facing a group of multi-colored figures.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
17
The slide illustrates the 'Approach' side of the conflict; the 'Avoidance' side is implied by the context of SAD.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
18
SAD likely stands for Social Anxiety Disorder. The diagram uses a circular flow to represent the internal conflict.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
19
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
20
Includes UC San Diego Health branding.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
21
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
22
The slide displays a snippet of the LSAS questionnaire, showing the scoring criteria for 'Fear or Anxiety' and 'Avoidance' and providing examples of the 24 items.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
23
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
24
The slide uses a circular crop for the image, which is a common design element in pitch decks to create visual interest.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
25
The slide uses a nested bulleted list to define the three core components of a behavioral challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
26
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
27
BNC210 refers to the Trier Social Stress Test (TSST) or a variant thereof used in clinical research.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
28
The slide details the constraints of the experiment: 5 topics, 2 min prep, 5 min speech, and 3 audience members.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
29
This is a standard clinical measurement tool for anxiety and distress levels.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
30
The table maps specific time intervals (pre-dose, resting, preparation, performance, post-challenge) to data collection points.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
31
The table highlights the 'Public Speaking Challenge - Performance' phase with a purple border.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
32
The chart displays data from Bergamaschi et al. (2011) regarding acute CBD treatment for Social Anxiety Disorder (SAD).Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
33
The chart highlights the efficacy of CBD in reducing anxiety during the 'A' (Anticipation) and 'S' (Speaking) phases of the challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
34
The chart highlights a statistically significant difference between CBD and Placebo groups during the speaking phase.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
35
The chart highlights the performance phase where the PH94B group shows a downward trend in distress compared to the placebo group.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
36
The slide uses a hierarchical list to detail the research methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
37
The chart highlights the 'Speech' phase with a box. SUDS is a standard clinical measure for anxiety.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
38
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
39
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
40
The slide uses a list-based layout with icons to summarize key company highlights.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Pareto Focus1 hit
41
Includes a legend for FDA Fast Track designation and definitions for NAM/PAM.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Pareto Focus1 hit
42
Includes a detailed biological process diagram and a conceptual model of disease state vs. normalized state.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
43
The table lists 13 rows, though the title mentions 12 trials; likely one trial is split or there is a discrepancy in the count.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit